GLP-1 Key Research Facts Full name: Glucagon-Like Peptide-1 incretin hormone of the proglucagon family Primary bioactive form: GLP-1(736)amide 30 amino acids, C-terminally amidated Gene source: Proglucagon gene processed by PCSK1 in intestinal L-cells and brainstem NTS neurons In vivo half-life: Approximately 12 minutes rapidly inactivated by DPP-4 (cleaves His7-Ala8 dipeptide) Primary receptor: GLP-1R (GLP-1 receptor) class B G protein-coupled receptor (GPCR) Signalling: GLP-1R activation cAMP elevation PKA/CREB activation glucose-dependent insulin secretion Additional signalling: PI3K/Akt pathway -cell survival, proliferation, and glucose sensitivity Secretion pattern: Biphasic post-meal release from intestinal L-cells early neural/endocrine peak + late direct nutrient-contact peak Fasting plasma level: ~510 pmol/L
Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine
While hyperbaric oxygen therapy has been established as a common method of oxygen delivery to wounds, it comes with challenges such as the high cost of treatments, limited indications for use and insurance reimbursement, claustrophobia, and travel time to facilities for lengthy daily therapy sessions
Avoiding these triggers is the most reliable prevention approach
Professional and Personalized Care Whether you feel drained, dehydrated, or simply need a wellness boost, our IV therapy services are designed to help replenish fluids, support recovery, and help you feel refreshed
